AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DIMERIX LTD

0.310

-0.015-4.62%

Volume:1.17M

Turnover:368.46K

Market Cap:186.12M

PE:-11.08

High:0.330

Open:0.325

Low:0.307

Close:0.325

52wk High:0.665

52wk Low:0.157

Shares:600.40M

Float Shares:467.70M

Volume Ratio:0.65

T/O Rate:0.25%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.028

EPS(LYR):-0.024

ROE:-594.54%

ROA:-58.27%

PB:-110.71

PE(LYR):-13.11

Loading ...

Overview Company News Filings

Dimerix Receives Initial $10 Million Upfront Payment Under Everest Medicines License Deal; Shares Gain 4%

MT Newswires Live

Dimerix Completes Transfer of Acute Kidney Injury Drug Candidate's US Investigational New Drug Application, Shares Up 6%

MT Newswires Live

Dimerix Ltd-Dimerix Assumes Sponsorship of US Ind for New Asset Dmx-652

THOMSON REUTERS

Soekarno-Hatta Set to Welcome Emirates' Giant A380

Dimerix Secures US Patent Regarding Kidney Injury Drug Candidate, Shares Jump 4%

MT Newswires Live

Dimerix Ltd-us Patent Granted for Dimerix New Asset Dmx-652

THOMSON REUTERS

Dimerix Acquires Phase 2-ready Acute Kidney Injury Drug Candidate Dmx-652 from Mission Therapeutics

Dimerix - Buys Dmx-652 for All Indications from Mission Therapeutics

THOMSON REUTERS

Dimerix - to Pay $5 Mln Upfront, up to $287 Mln in Milestones for Dmx-652

THOMSON REUTERS

Dimerix - to Pay 8-10% Royalty on Global Net Sales of Dmx-652

THOMSON REUTERS

Dimerix - Phase 2 Trial Ethics Approval Expected H2 2026, First Patient Dosing H1 2027

THOMSON REUTERS

Mission Therapeutics Divests Mtx652 for Acute Kidney Injury to Dimerix

THOMSON REUTERS

Mission Therapeutics: to Receive up to $292 Mln Plus Double-digit Tiered Royalties from Deal

THOMSON REUTERS

Dimerix Hits 'Major Milestone' With AU$10 Million Financing Package, Euroz Hartleys Says

MT Newswires Live

Australia's Dimerix Rises on Funding Boost and Pipeline Acquisition

Dimerix Acquires Therapeutic Asset from UK-Based Firm; Shares Up 8%

MT Newswires Live

Dimerix Secures AU$10 Million Loan Facility From Substantial Shareholder Associate; Shares Up 9%

MT Newswires Live

Dimerix Ltd-dimerix Expands Pipeline with Acquisition of Phase 2 Asset

THOMSON REUTERS

Dimerix Ltd - Initial A$10 Mln Loan Facility Secured

THOMSON REUTERS

Dimerix Requests Trading Halt

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/DXB.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DXB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","market":"AU","secType":"STK","nameCN":"DIMERIX LTD","latestPrice":0.31,"timestamp":1787292720000,"preClose":0.325,"halted":0,"volume":1167459,"delay":0,"changeRate":-0.04615384615384619,"nameEN":"DIMERIX LTD","floatShares":467696880,"shares":600396776,"eps":-0.027967,"marketStatus":"Market Closed","change":-0.015,"latestTime":"08-21 16:12:00 AEST","open":0.325,"high":0.33,"low":0.307,"amount":368460,"amplitude":0.070769,"askPrice":0.32,"askSize":26000,"bidPrice":0.305,"bidSize":51931,"shortable":3,"etf":0,"ttmEps":-0.027967,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.325,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.6515115207611286,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"DXB.AU","preClose":0.325,"auctionPrice":0.31,"auctionVolume":81184,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600775}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"DXB.AU\",,,,,undefined,":{"symbol":"DXB.AU","floatShares":467696880,"roa":"-58.27%","roe":"-594.54%","lyrEps":-0.023645,"volumeRatio":0.6515115207611286,"shares":600396776,"dividePrice":0,"high":0.33,"amplitude":0.070769,"preClose":0.325,"low":0.307,"week52Low":0.157,"pbRate":"-110.71","psRate":"25.10","week52High":0.665,"institutionHeld":0,"latestPrice":0.31,"committee":0.332743,"eps":-0.027967,"divideRate":0,"volume":1167459,"delay":0,"ttmEps":-0.027967,"open":0.325,"prevYearClose":0.55,"prevWeekClose":0.295,"prevMonthClose":0.245,"prevQuarterClose":0.205,"fiveDayClose":0.295,"twentyDayClose":0.25,"sixtyDayClose":0.175,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DXB.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DXB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DXB.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660340889","title":"Dimerix Receives Initial $10 Million Upfront Payment Under Everest Medicines License Deal; Shares Gain 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660340889","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660340889?lang=en_us&edition=fundamental","pubTime":"2026-08-20 11:53","pubTimestamp":1787197984,"startTime":"0","endTime":"0","summary":"Dimerix  received an initial $10 million upfront payment under a license agreement with Everest Medicines, according to a Thursday filing with the Australian bourse.Everest holds exclusive rights to commercialize DMX-200 for the treatment of kidney disease focal segmental glomerulosclerosis across Greater China, South Korea, and Southeast Asia.Dimerix said it is eligible to receive up to an additional $330 million in success-based development, regulatory, and commercial milestone payments, in addition to tiered royalties on net sales of the DMX-200 in the licensed regions.The company's shares gained 4% in recent Thursday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","DXB.AU","MDCO","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660243106","title":"Dimerix Completes Transfer of Acute Kidney Injury Drug Candidate's US Investigational New Drug Application, Shares Up 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660243106","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660243106?lang=en_us&edition=fundamental","pubTime":"2026-08-17 09:43","pubTimestamp":1786930994,"startTime":"0","endTime":"0","summary":"Dimerix  said it completed the transfer of the investigational new drug application in the US for its acute kidney injury drug candidate, DMX-652, from Mission Therapeutics, according to a Monday Australian bourse filing.Dimerix plans to advance DMX-652 into a phase 2 clinical trial for acute kidney injury associated with cardiac surgery during the second half, to investigate its potential to prevent kidney injury and preserve renal function.Its shares jumped 6% in recent trading on Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","DXB.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660875103","title":"Dimerix Ltd-Dimerix Assumes Sponsorship of US Ind for New Asset Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2660875103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660875103?lang=en_us&edition=fundamental","pubTime":"2026-08-17 06:38","pubTimestamp":1786919913,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nTUE7JZ8SR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7067","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655355611","title":"Soekarno-Hatta Set to Welcome Emirates' Giant A380","url":"https://stock-news.laohu8.com/highlight/detail?id=2655355611","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655355611?lang=en_us&edition=fundamental","pubTime":"2026-07-31 12:54","pubTimestamp":1785473684,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - Soekarno-Hatta International Airport, operated under InJourney Airports , is set to welcome the inaugural landing of Emirates Airlines' Airbus A380-800, which will operate flight EK358 from Dubai  to Jakarta .Soekarno-Hatta International Airport General Manager Heru Karyadi stated that the world's largest passenger airliner is scheduled to touch down in Jakarta on August 8, 2026, at 10:25 p.m. Jakarta time  before making its return journey to Dubai as flight EK359 on August 9, 2026, at 12:45 a.m. WIB.\"The arrival of the Airbus A380-800 is a major milestone in expanding Indonesia's international air connectivity,\" Heru said on Friday, July 31, 2026.","market":"sh","thumbnail":"https://statik.tempo.co/data/2023/06/02/id_1208747/1208747_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2023/06/02/id_1208747/1208747_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2116268/soekarno-hatta-set-to-welcome-emirates-giant-a380","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2116268/soekarno-hatta-set-to-welcome-emirates-giant-a380","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK7501","DXB","DXB.AU","BK7067","BK7508","PCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653797401","title":"Dimerix Secures US Patent Regarding Kidney Injury Drug Candidate, Shares Jump 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653797401","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653797401?lang=en_us&edition=fundamental","pubTime":"2026-07-23 09:27","pubTimestamp":1784770064,"startTime":"0","endTime":"0","summary":"Dimerix  said the United States Patent and Trademark Office granted a patent providing composition-of-matter-type claims covering the firm's drug candidate, DMX-652, until April 11, 2043, according to a Thursday Australian bourse filing.The candidate is a selective inhibitor of USP30, a mitochondrial enzyme, designed to prevent kidney injury and promote mitophagy where damage has occurred. A divisional application has also been filed to pursue additional claims covering DMX-652, the filing added.Its shares rose 4% in recent trading on Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7501","DXB.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653791917","title":"Dimerix Ltd-us Patent Granted for Dimerix New Asset Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2653791917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653791917?lang=en_us&edition=fundamental","pubTime":"2026-07-23 06:46","pubTimestamp":1784760416,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nTUE4PKSZB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","BK7501","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652407438","title":"Dimerix Acquires Phase 2-ready Acute Kidney Injury Drug Candidate Dmx-652 from Mission Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2652407438","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652407438?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:02","pubTimestamp":1784286128,"startTime":"0","endTime":"0","summary":"Dimerix acquires Phase 2-ready acute kidney injury drug candidate DMX-652 from Mission TherapeuticsDimerix acquired DMX-652 from Mission Therapeutics for all indications, adding a Phase 2-ready acute ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDLbGlB3s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Dimerix Acquires Phase 2-ready Acute Kidney Injury Drug Candidate Dmx-652 from Mission Therapeutics","news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","BK7508","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652740715","title":"Dimerix - Buys Dmx-652 for All Indications from Mission Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2652740715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652740715?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","DXB.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652152407","title":"Dimerix - to Pay $5 Mln Upfront, up to $287 Mln in Milestones for Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2652152407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652152407?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DXB.AU","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652074884","title":"Dimerix - to Pay 8-10% Royalty on Global Net Sales of Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2652074884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652074884?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7067","DXB.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652040713","title":"Dimerix - Phase 2 Trial Ethics Approval Expected H2 2026, First Patient Dosing H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2652040713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652040713?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","DXB.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652940871","title":"Mission Therapeutics Divests Mtx652 for Acute Kidney Injury to Dimerix","url":"https://stock-news.laohu8.com/highlight/detail?id=2652940871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652940871?lang=en_us&edition=fundamental","pubTime":"2026-07-17 15:32","pubTimestamp":1784273522,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nFWN43I1WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","BK7501","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652716408","title":"Mission Therapeutics: to Receive up to $292 Mln Plus Double-digit Tiered Royalties from Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2652716408","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652716408?lang=en_us&edition=fundamental","pubTime":"2026-07-17 15:32","pubTimestamp":1784273522,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nFWN43I1WH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7501","DXB.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652064471","title":"Dimerix Hits 'Major Milestone' With AU$10 Million Financing Package, Euroz Hartleys Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2652064471","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652064471?lang=en_us&edition=fundamental","pubTime":"2026-07-17 12:24","pubTimestamp":1784262255,"startTime":"0","endTime":"0","summary":"Dimerix's (ASX:DXB) AU$10 million financing package represents a \"major milestone\" as the company is now fully funded through the completion of its phase 3 focal segmental glomerulosclerosis study for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","BK7508","BK7067","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652476049","title":"Australia's Dimerix Rises on Funding Boost and Pipeline Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2652476049","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652476049?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:38","pubTimestamp":1784255930,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Dimerix rises on funding boost and pipeline acquisition** Shares of Australia's DimerixDXB.AXrise as much as 10.4% to A$0.265, their biggest intraday pct gain since July 6** Stock at its highest level since July 7** DXB stock set to mark its second consecutive session of gains, if trend holds** Stock up 2.1% in the week so far** The clinical stage biopharmaceutical firmsecuresa A$10 million  loan facility** Loan facility to support commercial manufacturing of DMX-200, a pill for kidney diseases, ahead of potential marketing approval submission and preparation for commercial launch, among others** Company separately says it expands pipeline with acquisition of DMX-652 for acute kidney injury** Near 4.7 million shares change hands, 1.5x the 30-day average** Stock has fallen 55.5% this year, including session moves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nL4N43J07T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","DXB.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652047509","title":"Dimerix Acquires Therapeutic Asset from UK-Based Firm; Shares Up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652047509","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652047509?lang=en_us&edition=fundamental","pubTime":"2026-07-17 09:45","pubTimestamp":1784252758,"startTime":"0","endTime":"0","summary":"Dimerix  acquired therapeutic asset DMX-652 for all indications from UK-based Mission Therapeutics for an upfront payment of $5 million, expanding the company's pipeline in rare kidney disease, according to a Friday filing with the Australian bourse.The company will also pay up to $47 million in deferred acquisition fee payable upon success of pre-defined clinical development milestones, $40 million on product marketing approval, $25 million on approval in a second indication, and up to $175 million on specific sales milestones, the filing said.The acquisition includes assignment of the composition-of-matter patent, an open Investigational New Drug application in the US with a phase two clinical trial protocol, a pharmaceutical-grade drug product for the trial, and all manufacturing methodology, per the filing.Dimerix shares rose 8% in morning trade on Friday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7501","DXB.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652739754","title":"Dimerix Secures AU$10 Million Loan Facility From Substantial Shareholder Associate; Shares Up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652739754","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652739754?lang=en_us&edition=fundamental","pubTime":"2026-07-17 08:39","pubTimestamp":1784248777,"startTime":"0","endTime":"0","summary":"Dimerix (ASX:DXB) entered into a loan facility agreement with Skiptan, an associate of substantial shareholder Peter Meurs, under which the lender has agreed to advance AU$10 million to the company at","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DXB.AU","BK7501","BK7067","BK7508","DMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652420035","title":"Dimerix Ltd-dimerix Expands Pipeline with Acquisition of Phase 2 Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2652420035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652420035?lang=en_us&edition=fundamental","pubTime":"2026-07-17 07:03","pubTimestamp":1784242987,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUEWCH2R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7508","BK7067","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652242008","title":"Dimerix Ltd - Initial A$10 Mln Loan Facility Secured","url":"https://stock-news.laohu8.com/highlight/detail?id=2652242008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652242008?lang=en_us&edition=fundamental","pubTime":"2026-07-17 07:02","pubTimestamp":1784242924,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43I20B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DXB.AU","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651314482","title":"Dimerix Requests Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2651314482","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651314482?lang=en_us&edition=fundamental","pubTime":"2026-07-15 06:43","pubTimestamp":1784068982,"startTime":"0","endTime":"0","summary":"BRIEF-Dimerix Requests Trading HaltJuly 15 (Reuters)-Dimerix LtdDXB.AX:TRADING HALT REQUESTED PENDING NON-DILUTIVE FUNDING AND ASSET ACQUISITION ANNOUNCEMENTSFurther company coverage:DXB.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G19H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","DXB.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":44,"code":"91000000","status":"200"}]}}